ResMed Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference
ResMed (NYSE: RMD, ASX: RMD) has announced that Mick Farrell, chairman and CEO, and Dr. Carlos Nunez, chief medical officer, will present at the 43rd Annual J.P. Morgan Healthcare Conference. The presentation is scheduled for Monday, January 13, 2025, at approximately 3:00 p.m. (Pacific Standard Time) in San Francisco, CA.
The company will provide an audio-only webcast of the presentation, which can be accessed through the investor relations section of ResMed's website. A replay of the webcast will be available for 30 days following the live presentation.
ResMed (NYSE: RMD, ASX: RMD) ha annunciato che Mick Farrell, presidente e CEO, e Dr. Carlos Nunez, Chief Medical Officer, presenteranno al 43° Annual J.P. Morgan Healthcare Conference. La presentazione è programmata per lunedì 13 gennaio 2025, alle circa 15:00 (Pacific Standard Time) a San Francisco, CA.
La società fornirà una trasmissione audio in diretta della presentazione, accessibile tramite la sezione relazioni con gli investitori del sito web di ResMed. Una registrazione della trasmissione sarà disponibile per 30 giorni dopo la presentazione dal vivo.
ResMed (NYSE: RMD, ASX: RMD) ha anunciado que Mick Farrell, presidente y CEO, y Dr. Carlos Nunez, director médico, presentarán en la 43ª Conferencia Anual de Atención Médica J.P. Morgan. La presentación está programada para el lunes 13 de enero de 2025, aproximadamente a las 3:00 p.m. (Hora Estándar del Pacífico) en San Francisco, CA.
La empresa proporcionará una transmisión solo de audio de la presentación, que se podrá acceder a través de la sección de relaciones con inversores del sitio web de ResMed. Una repetición de la transmisión estará disponible durante 30 días después de la presentación en vivo.
ResMed (NYSE: RMD, ASX: RMD)는 Mick Farrell 회장 겸 CEO와 Dr. Carlos Nunez 최고 의료 책임자가 제43회 연례 J.P. 모건 헬스케어 컨퍼런스에서 발표한다고 발표했습니다. 발표는 2025년 1월 13일 월요일, 태평양 표준시 기준으로 오후 3시경 샌프란시스코, CA에서 예정되어 있습니다.
회사는 ResMed 웹사이트의 투자자 관계 섹션을 통해 접근할 수 있는 오디오 전용 스트리밍을 제공할 예정입니다. 라이브 발표 이후 30일 동안 재청취가 가능합니다.
ResMed (NYSE: RMD, ASX: RMD) a annoncé que Mick Farrell, président et PDG, et Dr. Carlos Nunez, directeur médical, présenteront lors de la 43ème Conférence Annuelle J.P. Morgan Healthcare. La présentation est prévue pour le lundi 13 janvier 2025, vers 15h00 (heure normale du Pacifique) à San Francisco, CA.
L'entreprise proposera une retransmission audio uniquement de la présentation, qui pourra être consultée via la section des relations avec les investisseurs du site web de ResMed. Un enregistrement de la retransmission sera disponible pendant 30 jours après la présentation en direct.
ResMed (NYSE: RMD, ASX: RMD) hat bekannt gegeben, dass Mick Farrell, Vorsitzender und CEO, sowie Dr. Carlos Nunez, Chief Medical Officer, auf der 43. jährlichen J.P. Morgan Healthcare Conference präsentieren werden. Die Präsentation ist für Montag, den 13. Januar 2025, gegen 15:00 Uhr (Pacific Standard Time) in San Francisco, CA, angesetzt.
Das Unternehmen wird eine Audioübertragung der Präsentation zur Verfügung stellen, die über den Bereich Investorenbeziehungen auf der Website von ResMed zugänglich ist. Eine Wiederholung der Übertragung wird 30 Tage nach der Live-Präsentation verfügbar sein.
- None.
- None.
SAN DIEGO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Dr. Carlos Nunez, chief medical officer, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025, beginning at approximately 3:00 p.m. (Pacific Standard Time) in San Francisco, CA.
More information about this event, including access to the live, audio-only webcast, may be accessed by visiting https://investor.resmed.com. The audio-only webcast replay will be available approximately 24 hours after the live webcast ends and will be accessible for the following thirty (30) days.
About ResMed
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.
| For investors | For media |
| +1 858.836.5000 | +1 619.510.1281 |
| investorrelations@resmed.com | news@resmed.com |
FAQ
When is ResMed (RMD) presenting at the 2025 J.P. Morgan Healthcare Conference?
Who will represent ResMed (RMD) at the 2025 J.P. Morgan Healthcare Conference?
How long will ResMed's (RMD) J.P. Morgan conference presentation replay be available?
Where can investors access ResMed's (RMD) J.P. Morgan conference presentation?
